There are more than 50,000 global acne diagnosis cases to strengthen the prevention and control of monkey acne in many countries

Xinhua News Agency, Beijing, September 1st: There are more than 50,000 global acne diagnosis cases of more than 50,000 countries to strengthen monkey acne prevention and control

Xinhua News Agency reporter

According to the statistics of monkey acne epidemic released by the World Health Organization on August 31, there were 50,496 cumulative cumulative cases of acne acne and 16 cumulative death cases. WHO said that the epidemic in Canada and some European countries are slowing down, but the number of infections in some countries in the Americas is still increasing. In response to the epidemic of monkey acne, many countries have adopted a large number of prevention and control measures such as the purchase of monkey acne vaccines and strengthening monkey acne virus monitoring.

Monkey acne spread to hundreds of nations

Monkey acne is a kind of viral human and animal disease, which is caused by monkey acne virus infection. In the past, this infectious disease was mostly in West Africa and China Africa, but since May this year, many countries and regions outside Africa have reportedly reported monkey acne cases. WHO announced on July 23 that the epidemic of the monkey acne constituted a "international concern public health incident."

According to statistics from WHO, more than 100 member states divided into the six areas divided by the organization have reported the case of monkey acne since the beginning of this year. At present, America is the area with the most new cases of acne in the world. The latest data show that more than 60 % of the world ’s new cases of acne are from the American region, and the proportion of European regions has fallen to more than 30 %.

Data show that as of August 30, 10 countries with a large number of cases in the world reported that there were many cases of acne cases. The number of acne cases accounts for 88.5%of the total number of global monkey acne cases.

The number of cases of acne in the United States ranks first in the world. Data released by the Centers for Disease Control and Prevention show that as of August 30, more than 18,400 cases of acne diagnosis have been reported in the United States. The U.S. government announced in early August that the epidemic of the monkey acne was an emergency in the country.

American public health experts pointed out that due to insufficient testing capabilities, the number of cases of acne in the United States may be much higher than official statistics. Most suspected patients have not been tested in time and may pass the virus to more people. Experts say that the US government is making the same incompetence when it comes to the emergence of the new crown epidemic, and is backward and chaotic in terms of case data collection, testing and vaccine.

The Director -General of the WHO Tan Desai pointed out at a press conference on August 31 that the reduction of new cases in some countries proves that the epidemic can be curbed. In the Americas, which account for more than half of the cases of acne, although the number of infections in some countries has continued to increase, Canada has continued to decline. The epidemic in some European countries such as Germany and the Netherlands has also slowed down, which proves the effectiveness of public health intervention.

In response to the decline in the recent number of new monkey acne cases in many European countries, Hans Kuli, director of the European regional director of the WHO, said on August 30 that if countries have strengthened response measures, the European acne epidemic may be completely eliminated.

Multi -country monkey acne vaccine shortage

With the spread of monkey acne epidemic in Europe and the United States, some countries have begun to purchase a large number of monkey acne vaccines. However, due to the limited supply of acne vaccines, many European and American countries face the shortage of monkey acne vaccines.

The US Food and Drug Administration urgently authorized the new vaccination plan for monkey acne vaccine on August 9. The vaccination method was changed from subcutaneous injection to in -skin injection. The dose required for each injection was only one -five -fifth. American public opinion pointed out that this clearly shows that the government does not have enough vaccines to deal with the epidemic of the monkey acne.

The U.S. government said on August 18 that nearly 1 million doses of "Guinios" monkey acne vaccine has been distributed to various places. However, the New York Times disclosed that experts expect the current control of 3.5 million doses of vaccines.

The European Regulatory Institution European Pharmaceutical Administration announced on August 19 that, in view of the limited supply of acne vaccines produced by Danish Panana and Nordic companies, European countries can consider reducing the dose of vaccination for vaccination to expand the scope of vaccination. efficient. The European Pharmacy Administration recommends the use of the "one demolition and five" injection method, that is, the individual accepts two internal injections of monkey acne vaccine, and the inoculation interval is about 4 weeks.

The British Health and Safety Administration announced on August 22 that it would provide one -fifth of monkey acne vaccines for eligible people to expand the size of the population to protect the vaccine. The British Health and Safety Administration previously stated that the initially delivered 50,000 dose of acne vaccine will be used up by the end of August.

Multi -nation strictly prevent monkey acne

The Indonesian government is strengthening monkey acne prevention and control, adding 10 polymer enzyme chain reaction laboratories at the entry ports of the airport and port, and trying to obtain monkey acne vaccines.

Lithuania has ordered about 1,400 doses of monkey acne vaccines, and contacts with high risk of pox virus in infection will be vaccinated. In order to curb the spread of monkey acne epidemic, in addition to adopting measures such as vaccination for high -risk people and targeted science publicity, it has also established special line telephones to provide consultation services to the public.

The Israeli Ministry of Health has signed an agreement with the vaccine manufacturer to purchase 10,000 doses of acne vaccine, of which 5600 doses were delivered at the end of July, and the remaining 4,400 doses were expected to be delivered in September. From July 31st, Israeli high -risk people can vaccinate monkey acne vaccines. According to the Ministry of Health, more than 2,800 eligible Israelites vaccinated the vaccine.

- END -